Relationship between 25(OH)D and Colorectal Cancer Prevalence at Dr. Moewardi Hospital Surakarta-Indonesia: A Cross-Sectional Study

Tegoeh Winandar; Agus Raharjo; Hari Wujoso; B. Rina A. Sidharta; Budhi Ida Bagus

doi:10.3889/oamjms.2021.7396

Authors

Tegoeh Winandar Department of Surgery, Faculty of Medicine, Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia
Agus Raharjo Department of Surgery, Digestive Division, Faculty of Medicine, Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia
Hari Wujoso Department of Forensics, Faculty of Medicine, Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia
B. Rina A. Sidharta Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University, Dr, Moewardi Hospital, Surakarta, Indonesia
Budhi Ida Bagus Department of Surgery, Digestive Division, Faculty of Medicine, Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.7396

Keywords:

Colorectal cancer prevalence, 25(OH)D, Vitamin D, Dr. Moewardi Hospital

Abstract

Background: Colorectal cancer is a malignancy of the colon and / or rectum. Vitamin D has a role as an inhibitor of tumor progression, namely through the process of influencing cellular differentiation and proliferation. (VDR) Vitamin D Receptor affects cell differentiation by upregulating brush boundary enzymes and improving morphological microvilli. This study seeks to determine the relationship between 25(OH)D levels and colorectal cancer in dr. Moewardi Hospital, Surakarta, Indonesia.

Methods: A cross-sectional design study with quantitative-analytical observation was conducted. All patients had symptoms of colorectal cancer, either undiagnosed or previously diagnosed. 25(OH)D samples were taken from a total of 50 patients at dr. Moewardi Surakarta and subsequent diagnostic measures from the results of histopathology were assessed. The parameters assessed were 25(OH)D level and a diagnosis of colorectal malignancy. Statistical analysis of 25(OH)D levels and colorectal diagnosis using the Chi Square test.

Results: The prevalence of colorectal cancer is higher in respondents with 25(OH)D deficiency and insufficiency compared to respondents with normal 25(OH)D concentrations who tend to have non-colorectal cancer. Based on the Chi-Square test result, the significance value was 0.004, marking a statistically significant association.

Conclusion: This study shows a significant relationship between deficiency and insufficiency of 25(OH)D concentrations with the occurrence of colorectal malignancy

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Rasmussen S, Larsen P V, Søndergaard J, Elnegaard S, Svendsen RP, Jarbøl DE. Specific and non-specific symptoms of colorectal cancer and contact to general practice. Fam Pract. 2015;32(4):387-94. https://doi.org/10.1093/fampra/cmv032 PMid:25977134 DOI: https://doi.org/10.1093/fampra/cmv032

Abdullah M, Sudoyo AW, Utomo AR, Fauzi A, Rani AA. Molecular profile of colorectal cancer in Indonesia: Is there another pathway? Gastroenterol Hepatol Bed Bench. 2012;5(2):71-8. PMid:24834203

Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57. https://doi.org/10.1038/nrc3691 PMid:24705652 DOI: https://doi.org/10.1038/nrc3691

Erida Y, Aminah H, Yulianti H, Hernowo BS. Vitamin D receptor (VDR) and phosphatidylinositol 3-Kinase (PI3K) independently affected colorectal adenocarcinoma differentiation. Indones J Clin Pharm. 2015;4(4):264-74. DOI: https://doi.org/10.15416/ijcp.2015.4.4.264

González-Sancho JM, Larriba MJ, Ordóñez-Morán P, Pálmer HG, Muñoz A. Effects of 1α,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 2006;26(4A):2669-81. PMid:16886677

Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 2006;35(2):217-20. PMid:16303809 DOI: https://doi.org/10.1093/ije/dyi229

Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, Ogino S. Vitamin D and colorectal cancer: Molecular, epidemiological, and clinical evidence. Br J Nutr. 2016;115:1643-60. https://doi.org/10.1017/S0007114516000696 PMid:27245104 DOI: https://doi.org/10.1017/S0007114516000696

Fuchs MA, Yuan C, Sato K, Niedzwiecki D, Ye X, Saltz LB, et al. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017;28(6):1359-67. https://doi.org/10.1093/annonc/mdx109 PMid:28327908 DOI: https://doi.org/10.1093/annonc/mdx109

Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, et al. Association between pre-diagnostic circulating Vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study. BMJ. 2010;340:1-10. DOI: https://doi.org/10.1136/bmj.b5500

Pusparini P. Defisiensi Vitamin D terhadap penyakit. Indones J Clin Pathol Med Lab. 2014;21(1):90-5. DOI: https://doi.org/10.24293/ijcpml.v21i1.1265

Emmen JM, Wielders JP, Boer AK, Van Den Ouweland JM, Vader HL. The new roche Vitamin D total assay: Fit for its purpose ? Clin Chem Lab Med. 2012;50(11):1969-72. https://doi.org/10.1515/cclm-2011-0085 PMid:23113978 DOI: https://doi.org/10.1515/cclm-2011-0085

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: Serum Vitamin D and colorectal adenoma risk. Prev Med (Baltim). 2011;53(1-2):10-6. https://doi.org/10.1016/j.ypmed.2011.05.013 PMid:21672549 DOI: https://doi.org/10.1016/j.ypmed.2011.05.013

Lee JE. Circulating levels of Vitamin D, Vitamin D receptor polymorphisms, and colorectal adenoma: A meta-analysis. Nutr Res Pract. 2011;5(5):464-70. https://doi.org/10.4162/nrp.2011.5.5.464 PMid:22125685 DOI: https://doi.org/10.4162/nrp.2011.5.5.464

Zhang L, Zou H, Zhao Y, Hu C, Atanda A, Qin X, et al. Association between blood circulating Vitamin D and colorectal cancer risk in Asian countries: A systematic review and dose-response meta-analysis. BMJ Open. 2019;9(12):1-13. https://doi.org/10.1136/bmjopen-2019-030513 PMid:31874870 DOI: https://doi.org/10.1136/bmjopen-2019-030513

Ekmekcioglu C, Haluza D, Kundi M. 25-hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetes mellitus: A systematic review and meta-analysis of epidemiological studies. Int J Environ Res Public Health. 2017;14(2):127. https://doi.org/10.3390/ijerph14020127 PMid:28134804 DOI: https://doi.org/10.3390/ijerph14020127

O’Mahony L, Stepien M, Gibney MJ, Nugent AP, Brennan L. The potential role of Vitamin D enhanced foods in improving Vitamin D status. Nutrients. 2011;3(12):1023-41. https://doi.org/10.3390/nu3121023 PMid:22292109 DOI: https://doi.org/10.3390/nu3121023

Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498-513. https://doi.org/10.1038/s41430-020-0558-y PMid:31959942 DOI: https://doi.org/10.1038/s41430-020-0558-y

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of Vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. https://doi.org/10.1210/jc.2011-0385 PMid:21646368 DOI: https://doi.org/10.1210/jc.2011-0385

Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, et al. Dietary reference values for Vitamin D. EFSA J. 2016;14(10):4547. DOI: https://doi.org/10.2903/j.efsa.2016.4592

Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, et al. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res. 2009;69(3):967-75. https://doi.org/10.1158/0008-5472.CAN-08-2307 PMid:19141646 DOI: https://doi.org/10.1158/0008-5472.CAN-08-2307

Bikle D. Vitamin D: Production, metabolism, and mechanisms of action. In: Feingold K, Anawalt B, Boyce A, editors. Endotext. South Dartmouth: MDText; 2017.

Ting H, Bao B, Reeder JE, Messing EM, Lee Y. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1 A, 25-dihydroxyvitamin D3 responsiveness. Mol Cancer Res. 2007;5(9):967-81. https://doi.org/10.1158/1541-7786.MCR-06-0318 PMid:17855664 DOI: https://doi.org/10.1158/1541-7786.MCR-06-0318

Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, et al. Vitamin D status in patients with stage IV colorectal cancer: Findings from intergroup trial N9741. J Clin Oncol. 2011;29(12):1599-606. https://doi.org/10.1200/JCO.2010.31.7255 PMid:21422438 DOI: https://doi.org/10.1200/JCO.2010.31.7255

Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, et al. Effect of high-dose vs standard-dose Vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA. 2019;321(14):1370-9. https://doi.org/10.1001/jama.2019.2402 PMid:30964527 DOI: https://doi.org/10.1001/jama.2019.2402